Metformin in Diabetic Patients Undergoing Coronary Angiography
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT04766008
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Humanitas Hospital, Italy
- Registry
-
NCT04766008
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT04766008. Allocation not applicable; no masking; primary purpose prevention. Start 2020-01-15 (actual); primary completion 2022-04-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin in Diabetic Patients Undergoing Coronary Angiography
- Acronym
- NO-STOP
- Condition
- Diabetes Mellitus
- Condition
- Coronary Artery Disease
- Condition
- Lactic Acidosis With Diabetes Mellitus
- Condition
- Contrast-induced Nephropathy
- Condition
- Metformin Associated Lactic Acidosis
- Intervention (Drug)
- Metformin
- Lead sponsor
- Humanitas Hospital, Italy
Record details
- Record id
cardio:ct-nct04766008- Content hash
c9d8d53ccc59ba201d04c02fcf934e20699523df96ffb74763ff0e90eaf4c34d